|Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration|
JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ...
The Lancet Neurology 12 (8), 822-838, 2013
|Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient …|
J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ...
The Lancet 384 (9958), 1929-1935, 2014
|The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST …|
IST-3 Collaborative Group
The Lancet 379 (9834), 2352-2363, 2012
|Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage|
CS Anderson, E Heeley, Y Huang, J Wang, C Stapf, C Delcourt, R Lindley, ...
N Engl j Med 368, 2355-2365, 2013
|Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis|
JM Wardlaw, V Murray, E Berge, G Del Zoppo, P Sandercock, RL Lindley, ...
The Lancet 379 (9834), 2364-2372, 2012
|Distinguishing between stroke and mimic at the bedside: the brain attack study|
PJ Hand, J Kwan, RI Lindley, MS Dennis, JM Wardlaw
Stroke 37 (3), 769-775, 2006
|The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke|
P Sandercock, R Collins, C Counsell, B Farrell, R Peto, J Slattery, ...
The Lancet 349 (9065), 1569, 1997
|Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial|
J Bernhardt, P Langhorne, RI Lindley, AG Thrift, F Ellery, J Collier, ...
Lancet 386 (9988), 46-55, 2015
|Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.|
PA Sandercock, AG Van den Belt, RI Lindley, J Slattery
Journal of Neurology, Neurosurgery & Psychiatry 56 (1), 17-25, 1993
|Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke|
CS Anderson, T Robinson, RI Lindley, H Arima, PM Lavados, TH Lee, ...
New England Journal of Medicine 374 (24), 2313-2323, 2016
|MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease …|
T Meade, P Sleight, R Collins, J Armitage, S Parish, R Peto, L Youngman, ...
European Heart Journal 20 (10), 1999
|Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study|
C Delcourt, Y Huang, H Arima, J Chalmers, SM Davis, EL Heeley, J Wang, ...
Neurology 79 (4), 314-319, 2012
|Sensory and cognitive association in older persons: findings from an older Australian population|
T Tay, JJ Wang, A Kifley, R Lindley, P Newall, P Mitchell
Gerontology 52 (6), 386-394, 2006
|Interobserver reliability of a clinical classification of acute cerebral infarction.|
RI Lindley, CP Warlow, JM Wardlaw, MS Dennis, J Slattery, ...
Stroke 24 (12), 1801-1804, 1993
|Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial|
L Manning, Y Hirakawa, H Arima, X Wang, J Chalmers, J Wang, R Lindley, ...
The Lancet Neurology 13 (4), 364-373, 2014
|Can simple questions assess outcome after stroke?|
RI Lindley, F Waddell, M Livingstone, P Sandercock, MS Dennis, ...
Cerebrovascular Diseases 4 (4), 314-324, 1994
|Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction|
RI Lindley, JM Wardlaw, PAG Sandercock, P Rimdusid, SC Lewis, ...
Journal of Stroke and Cerebrovascular Diseases 13 (6), 235-246, 2004
|MR diffusion-weighted imaging and outcome prediction after ischemic stroke|
PJ Hand, JM Wardlaw, CS Rivers, PA Armitage, ME Bastin, RI Lindley, ...
Neurology 66 (8), 1159-1163, 2006
|Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial|
L Koops, RI Lindley
Bmj 325 (7361), 415, 2002
|Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs|
P Sandercock, E Berge, M Dennis, J Forbes, P Hand, J Kwan, S Lewis, ...
Stroke 35 (6), 1490-1497, 2004